Structural Heart Devices Market
Opportunities and Forecasts, 2014 - 2022
No Of Pages: 274
Published Date: Feb 2017
Introduction to Structural Heart Devices Market
• Structural Heart Devices Market Report, published by Allied Market Research, forecasts that the global market was valued at $6,006 million in 2015, and is expected to reach $12,076 million by 2022, supported by a CAGR of 10.5% during the forecast period 2016 - 2022. •
The structural heart repair devices segment held nearly half of the total market share in 2015, and is expected to dominate during the forecast period.
• Rise in incidence of aortic stenosis, introduction of technologically advanced products (such as the Trifecta valve with Glide Technology), and increase in awareness about the benefits and availability of structural heart devices worldwide are major factors that drive the market growth. •
In addition, increase in number of application areas for repair and replacement devices coupled with its rise in adoption of annuloplasty rings and tissue valves is expected to further fuel this growth.
Introduction to Structural Heart Devices Market
• However, stringent approval process and high cost of surgeries restrict the market growth. • Tissue heart valves is expected to maintain its dominant position throughout the analysis period, due to its significant property of low requirement of anticoagulants, which reduces incidence of bleeding and thereby lowers the usage of anticoagulant by the patient. • The occluders segment accounted for two-fifths of the overall structural heart repair devices market in 2015, owing to its benefits in the treatment of congenital heart diseases and high adoption rate. • In addition, annuloplasty ring is projected to register the highest CAGR of 13.3% during the forecast period.
Structural Heart Devices Market Key Segments
Repair Devices
By Product
Structural Heart Devices Market
Replacement Valves Atrial Septal Defect (ASD)
By Indication
By Age Group
Patent Foramen Ovale (PFO)
Pediatric Adults
Structural Heart Devices Market By Products
Structural Heart Devices Market Dynamics ďƒ˜ Drivers o Rise in number of patients suffering from structural heart diseases. o Increase in risk of cardiovascular diseases owing to growing globalization and industrialization. o Technological advancements in heart repair and replacement devices Growth in demand for minimally invasive procedures ďƒ˜ Restraints o High cost and risk associated with the treatment procedures o Stringent approval process for structural heart devices
Key Benefits of Structural Heart Devices Market • The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets. • It offers a quantitative analysis from 2014 to 2022 to enable stakeholders to capitalize on the prevailing market opportunities. • Extensive analysis of the market based on products helps to understand the type of devices used to treat structural heart diseases. • Competitive intelligence highlights the business practices followed by leading players across various regions. • Comprehensive analysis of all geographical regions helps to determine the prevailing opportunities. • Key players and their strategies are analyzed to understand the competitive outlook of the overall market.
Structural Heart Devices Market By Geography
North America
Europe
Asia-Pacific
Key Players Operating in Structural Heart Devices Market • Medtronic plc • St. Jude Medical, Inc. • Braile Biomedica • Medical Technology Est
• Boston Scientific Corporation • Micro Interventional Devices Inc • Edwards Lifesciences Corporation • LivaNova PLC • JenaValve Technology, Inc
• Cryolife, Inc.
Thank You!
For More Details Visit us at https://www.alliedmarketresearch.com/structural-heart-devices-market
Follow Us On